Kevin Pruitt

Kevin Pruitt is an Associate Professor in the Department of Pharmacology at the University of North Carolina School of Medicine. His research bridges cancer epigenetics, Wnt signaling, and aromatase regulation, with a focus on understanding how epigenetic enzymes modulate oncogenic pathways and tumor-immune interactions. Key projects include:

• Elucidating epigenetic drivers in cancer progression and immune evasion
• Investigating nuclear and cytosolic roles of Dishevelled proteins in Wnt signaling
• Decoding mechanisms of aromatase dysregulation in breast cancer

Research Trends: Recent publications highlight his work on the tumor microenvironment (e.g., cryoablation-induced immune changes, Sertoli cell immunoregulation) and nuclear Wnt signaling (e.g., Dishevelled localization, transcriptional targets). His studies often intersect with epigenetic therapies and hormone-sensitive cancers.

Education & Affiliation: While specific educational details are not provided, his academic career spans institutions like LSU Health Sciences Center and UNC Chapel Hill. He leads the Pruitt Lab, focusing on epigenetic and Wnt pathway interactions.

Collaborative Networks: Frequent co-authors include experts in cancer biology, immunology, and molecular genetics, such as Drs. Layeequr Rahman, Suresh Ramachandran, and Sandra Almodovar.